When and how to treat essential thrombocythemia

被引：51

作者：

Barbui, T ^{[1
]}

Finazzi, G ^{[1
]}

机构：

[1] Osped Riuniti Bergamo, Div Hematol, I-24100 Bergamo, Italy

来源：

NEW ENGLAND JOURNAL OF MEDICINE | 2005年 / 353卷 / 01期

关键词：

D O I：

10.1056/NEJMe058093

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：85 / 86

页数：2

共 15 条

[1] Barbui T, 2004, HAEMATOLOGICA, V89, P215
[2] Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders
Baxter, EJ
Scott, LM
Campbell, PJ
East, C
Fourouclas, N
Swanton, S
Vassiliou, GS
Bench, AJ
Boyd, EM
Curtin, N
Scott, MA
Erber, WN
Green, AR
[J]. LANCET, 2005, 365 (9464) : 1054 - 1061
[3] Myelofibrosis with myeloid metaplasia following essential thrombocythaemia:: actuarial probability, presenting characteristics and evolution in a series of 195 patients
Cervantes, F
Alvarez-Larrán, A
Talarn, C
Gómez, M
Montserrat, E
[J]. BRITISH JOURNAL OF HAEMATOLOGY, 2002, 118 (03) : 786 - 790
[4] HYDROXYUREA FOR PATIENTS WITH ESSENTIAL THROMBOCYTHEMIA AND A HIGH-RISK OF THROMBOSIS
CORTELAZZO, S
FINAZZI, G
RUGGERI, M
VESTRI, O
GALLI, M
RODEGHIERO, F
BARBUI, T
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 1995, 332 (17) : 1132 - 1136
[5] INCIDENCE AND RISK-FACTORS FOR THROMBOTIC COMPLICATIONS IN A HISTORICAL COHORT OF 100 PATIENTS WITH ESSENTIAL THROMBOCYTHEMIA
CORTELAZZO, S
VIERO, P
FINAZZI, G
DEMILIO, A
RODEGHIERO, F
BARBUI, T
[J]. JOURNAL OF CLINICAL ONCOLOGY, 1990, 8 (03) : 556 - 562
[6] Falanga A, 2000, BLOOD, V96, P4261
[7] Acute leukemia in polycythemia vera: an analysis of 1638 patients enrolled in a prospective observational study
Finazzi, G
Caruso, V
Marchioli, R
Capnist, G
Chisesi, T
Finelli, C
Gugliotta, L
Landolfi, R
Kutti, J
Gisslinger, H
Marilus, R
Patrono, C
Pogliani, EM
Randi, ML
Villegas, A
Tognoni, G
Barbui, T
[J]. BLOOD, 2005, 105 (07) : 2664 - 2670
[8] Hydroxyurea compared with anagrelide in high-risk essential thrombocythemia
Harrison, CN
Campbell, PJ
Buck, G
Wheatley, K
East, CL
Bareford, D
Wilkins, BS
van der Walt, JD
Reilly, JT
Grigg, AP
Revell, P
Woodcock, BE
Green, AR
Pearson, TC
Conneally, E
Crawley, C
Cross, NCP
Hall, G
Hunt, B
Lucas, G
Ludlam, C
McMullin, MF
Oscier, D
Radia, D
Reilly, JT
Robinson, G
Culligan, DJ
Tighe, J
Watson, HG
Warren, AJ
Awaad, MO
Obeid, D
Cuthbert, RJG
Kyle, A
Chan-Lam, D
Paul, B
Cuthbert, RJG
McMullin, MF
Morris, TCM
Johnson, RJ
Fegan, C
Milligan, DW
Galloway, MJ
Williamson, PJ
Newton, LJ
Williams, AT
Abboudi, Z
Ryan, K
Lush, R
Blundell, E
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (01) : 33 - 45
[9] A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera
James, C
Ugo, V
Le Couédic, JP
Staerk, J
Delhommeau, F
Lacout, C
Garçon, L
Raslova, H
Berger, R
Bennaceur-Griscelli, A
Villeval, JL
Constantinescu, SN
Casadevall, N
Vainchenker, W
[J]. NATURE, 2005, 434 (7037) : 1144 - 1148
[10] A gain-of-function mutation of JAK2 in myeloproliferative disorders
Kralovics, R
Passamonti, F
Buser, AS
Teo, S
Tiedt, R
Passweg, JR
Tichelli, A
Cazzola, M
Skoda, RC
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (17) : 1779 - 1790

← 1 2 →